Effects of Ticagrelor and Intracoronary Morphine on Myocardial Salvage in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

Trial Profile

Effects of Ticagrelor and Intracoronary Morphine on Myocardial Salvage in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

Recruiting
Phase of Trial: Phase II

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Ticagrelor (Primary) ; Clopidogrel; Morphine
  • Indications Myocardial infarction; Stroke; Thrombosis; Venous thromboembolism
  • Focus Pharmacodynamics
  • Most Recent Events

    • 04 Jul 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Dec 2016.
    • 03 Jul 2013 Planned end date changed from 1 Dec 2015 to 31 Dec 2015 as reported by Korean Clinical Trials Register record.
    • 03 Jul 2013 New source identified and integrated (Clinical Research Information Service (CriS) - Republic of Korea; KCT0000757).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top